| Indiana Blood And Marrow Transplantation Llc | |
|
8111 S Emerson Ave Suite 105 Indianapolis IN 46237-8601 | |
| (317) 528-5500 | |
| (317) 528-7356 |
| Full Name | Indiana Blood And Marrow Transplantation Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 8111 S Emerson Ave, Indianapolis, Indiana |
| Authorized Official Name and Position | Donna Phalen (DIRECTOR REV INTEGRITY) |
| Authorized Official Contact | 2195544548 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Indiana Blood And Marrow Transplantation Llc Po Box 781090 Detroit MI 48278-1090 Ph: (317) 528-4800 | Indiana Blood And Marrow Transplantation Llc 8111 S Emerson Ave Suite 105 Indianapolis IN 46237-8601 Ph: (317) 528-5500 |
| NPI Number | 1275647083 |
|---|---|
| Provider Enumeration Date | 08/18/2006 |
| Last Update Date | 09/19/2023 |
| Medicare PECOS PAC ID | 2264558626 |
|---|---|
| Medicare Enrollment ID | O20100923000555 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275647083 | NPI | - | NPPES |
| 100131340 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Anand Tandra |
|---|---|
| Provider Type | Practitioner - Hematopoietic Cell Transplantation And Cellular Therapy |
| Provider Identifiers | NPI Number: 1649495854 PECOS PAC ID: 2769574110 Enrollment ID: I20070815000594 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | Michael J Dugan |
|---|---|
| Provider Type | Practitioner - Hematopoietic Cell Transplantation And Cellular Therapy |
| Provider Identifiers | NPI Number: 1437263399 PECOS PAC ID: 8628194990 Enrollment ID: I20101007001378 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | Luke P Akard |
|---|---|
| Provider Type | Practitioner - Hematology/oncology |
| Provider Identifiers | NPI Number: 1780798660 PECOS PAC ID: 9537285903 Enrollment ID: I20101007001411 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | John R Edwards |
|---|---|
| Provider Type | Practitioner - Hematopoietic Cell Transplantation And Cellular Therapy |
| Provider Identifiers | NPI Number: 1487692794 PECOS PAC ID: 2860628807 Enrollment ID: I20131120001989 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | Francine M Figg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629511365 PECOS PAC ID: 5991087801 Enrollment ID: I20170127001787 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | Felix Augustine Mensah |
|---|---|
| Provider Type | Practitioner - Hematopoietic Cell Transplantation And Cellular Therapy |
| Provider Identifiers | NPI Number: 1508036559 PECOS PAC ID: 4880864883 Enrollment ID: I20210723002686 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
| Provider Name | Samantha Jo Levering |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194476036 PECOS PAC ID: 2163878653 Enrollment ID: I20231019000329 |
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
News Archive
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.
Skin cancer causes more than 1000 deaths in Australia, and costs the health care system over $700 million each year.
Teledermatology significantly improved access to specialized skin care for a group of patients that traditionally has limited options, according to an independent study led by researchers at the RAND Corporation and Harvard Medical School's Department of Health. The findings appear in a JAMA Dermatology article published online May 4.
Taking a vitamin A derivative called isotretinoin did not reduce the risk of second primary tumors or improve survival in patients with stage I or II head and neck squamous cell cancers (HNSCC), according to a study in the Journal of the National Cancer Institute.
As part of its mission to accelerate the adoption of health information exchange throughout California, the UC Davis Institute for Population Health Improvement's California Health eQuality program awarded $400,000 to L.A. Care, the nation's largest publicly operated health plan, to develop Blue Button functionality.
› Verified 3 days ago
Moazzam Habib Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9240 N Meridian St, Suite 240, Indianapolis, IN 46260 Phone: 317-571-0030 Fax: 317-571-0031 | |
Shalom 56th Street-new Access Point Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5750 W 56th St, Indianapolis, IN 46254 Phone: 317-291-7422 Fax: 317-291-4912 | |
Franciscan Health Indianapolis & Mooresville Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5230a East Stop 11 Road, Suite 250, Indianapolis, IN 46237 Phone: 317-528-8921 Fax: 317-528-6916 | |
Evernorth Care Providers - Delaware Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8888 Keystone Xing Ste 1300, Indianapolis, IN 46240 Phone: 773-292-4800 Fax: 312-564-4059 | |
Eskenazi Health Center Cottage Corner Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1434 Shelby St, Indianapolis, IN 46203 Phone: 317-655-3200 Fax: 317-655-3210 | |
Hello Wellness Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1040 E 86th St, Suite 48-a, Indianapolis, IN 46240 Phone: 317-569-1800 | |
Indiana Neurodiagnostics, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9465 Counselors Row, Ste. 200 Office 257, Indianapolis, IN 46240 Phone: 317-614-0310 Fax: 866-279-4704 |